Zusammenfassung
In der chinesischen Medizin ist der Einsatz des Pilzes
Ganoderma lucidum zur Gesundheitsförderung, aber
auch bei Indikationen wie z.B. Krebserkrankungen seit langem dokumentiert.
Pharmakologische Untersuchungen deuten darauf hin, dass bestimmte Inhaltsstoffe
antitumoröse und immunstimulierende Wirkungen haben können.
Tummorhemmende Effekte wurden sowohl in vitro als auch
im Tierversuch nachgewiesen. Es fehlen aber klinische Studien, die den Einsatz
des Pilzes in der Krebsbehandlung begründen würden.
Summary
Pharmaceutical application and anti-tumour
activity of Ganoderma lucidum.
In Chinese Medicine, the usage of the mushroom Ganoderma lucidum is well documented, particularly to
maintain and improve health, but also to treat patients with cancer. Several
pharmaceutical studies were performed to verify the efficacy of distinct
compounds from Ganoderma lucidum. Tumour-inhibiting
effects were reported in vitro and in animal
experiments. Nevertheless, only a few clinical studies have been undertaken to
prove its efficacy in the treatment of tumour patients. The available data pool
offers at least some hints about the possible utility of Ganoderma and thus a basis for promoting the mushroom's
pharmaceutically effective extracts to the status of supplements in general
health maintenance. To verify beneficial effects of Ganoderma lucidum in the treatment of tumour patients,
well planed clinical studies are still necessary.
Schlüsselwörter
Ganoderma lucidum - Immunmodulation - Zytotoxizität - klinische Studien - Tumorpatienten
Keywords
Ganoderma lucidum - immunomodulation - cytotoxicity - clinical studies - tumour patients
Literatur
- 01
Boh B, Berovic M, Zhang J, Zhi-Bin L.
Ganoderma lucidum and its pharmaceutically active
compounds.
Biotechnol Annu Rev.
2007;
13
265-301
- 02
Chan W K, Lam D T, Law H K, Wong W T, Koo M W, Lau A S. et al .
Ganoderma lucidum mycelium and spore extracts as natural
adjuvants for immunotherapy.
J Altern Complement Med.
2005;
11
(6)
1047-1057
- 03
Chan W K, Law H K, Lin Z B, Lau Y L, Chan G C.
Response of human dendritic cells to different
immunomodulatory polysaccharides derived from mushroom and barley.
Int Immunol.
2007;
19
(7)
891-899
- 04
Chen X, Hu Z P, Yang X X, Huang M, Gao Y, Tang W. et al .
Monitoring of immune responses to a herbal immuno-modulator
in patients with advanced colorectal cancer.
Int Immunopharmacol.
2006;
6
(3)
499-508
- 05
Cheng K C, Huang H C, Chen J H, Hsu J W, Cheng H C, Ou C H. et al .
Ganoderma lucidum polysaccharides in human monocytic leukemia
cells: from gene expression to network construction.
BMC Genomics.
2007;
8
411
- 06
Gao Y, Gao H, Chan E, Tang W, Xu A, Yang H. et al .
Antitumor activity and underlying mechanisms of ganopoly, the
refined polysaccharides extracted from Ganoderma lucidum, in mice.
Immunol Invest.
2005;
34
(2)
171-198
- 07
Gao Y, Tang W, Dai X, Gao H, Chen G, Ye J. et al .
Effects of water-soluble Ganoderma lucidum polysaccharides on
the immune functions of patients with advanced lung cancer.
J Med Food.
2005;
8
(2)
159-168
- 08
Gao Y, Zhou S, Jiang W, Huang M, Dai X.
Effects of ganopoly (a Ganoderma lucidum polysaccharide
extract) on the immune functions in advanced-stage cancer patients.
Immunol Invest.
2003;
32
(3)
201-215
- 09
Ji Z, Tang Q, Zhang J, Yang Y, Jia W, Pan Y.
Immunomodulation of RAW264.7 macrophages by GLIS, a
proteopolysaccharide from Ganoderma lucidum.
J Ethnopharmacol.
2007;
112
(3)
445-450
- 10
Jiang J, Grieb B, Thyagarajan A, Sliva D.
Ganoderic acids suppress growth and invasive behavior of
breast cancer cells by modulating AP-1 and NF-kappaB signaling.
Int J Mol Med.
2008;
21
(5)
577-584
- 11
Jiang J, Slivova V, Harvey K, Valachovicova T, Sliva D.
Ganoderma lucidum suppresses growth of breast cancer cells
through the inhibition of Akt/NF-kappaB signaling.
Nutr Cancer.
2004;
49
(2)
209-216
- 12
Jiang J, Slivova V, Sliva D.
Ganoderma lucidum inhibits proliferation of human breast
cancer cells by down-regulation of estrogen receptor and NF-kappaB
signaling.
Int J Oncol.
2006;
29
(3)
695-703
- 13
Kashimoto N, Hayama M, Kamiya K, Watanabe H.
Inhibitory effect of a water-soluble extract from the culture
medium of Ganoderma lucidum (Rei-shi) mycelia on the development of pulmonary
adenocarcinoma induced by N-nitrosobis (2-hydroxypropyl) amine in Wistar
rats.
Oncol Rep.
2006;
16
(6)
1181-1187
- 14
Kim K C, Kim J S, Son J K, Kim I G.
Enhanced induction of mitochondrial damage and apoptosis in
human leukemia HL-60 cells by the Ganoderma lucidum and Duchesnea chrysantha
extracts.
Cancer Lett.
2007;
246
(1–2)
210-217
- 15
Kwok Y, Ng K F, Li C C, Lam C C, Man R Y.
A prospective, randomized, double-blind, placebo-controlled
study of the platelet and global hemostatic effects of Ganoderma lucidum
(Ling-Zhi) in healthy volunteers.
Anesth Analg.
2005;
101
(2)
423-6
- 16
Lin Z B.
Cellular and molecular mechanisms of immuno-modulation by
Ganoderma lucidum.
J Pharmacol Sci.
2005;
99
(2)
144-153
- 17
Liu J, Shimizu K, Konishi F, Kumamoto S, Kondo R.
The anti-androgen effect of ganoderol B isolated from the
fruiting body of Ganoderma lucidum.
Bioorg Med Chem.
2007;
15
(14)
4966-4972
- 18
Muller C I, Kumagai T, O'Kelly J, Seeram N P, Heber D, Koeffler H P.
Ganoderma lucidum causes apoptosis in leukemia, lymphoma and
multiple myeloma cells.
Leuk Res.
2006;
30
(7)
841-848
- 19
Nonaka Y, Shibata H, Nakai M, Kurihara H, Ishibashi H, Kiso Y. et al .
Anti-tumor activities of the antlered form of Ganoderma
lucidum in allogeneic and syngeneic tumor-bearing mice.
Biosci Biotechnol Biochem.
2006;
70
(9)
2028-2034
- 20
Pang X, Chen Z, Gao X, Liu W, Slavin M, Yao W. et al .
Potential of a novel polysaccharide preparation (GLPP) from
Anhui-grown Ganoderma lucidum in tumor treatment and immunostimulation.
J Food Sci.
2007;
72
(6)
435-S442
- 21
Paterson R R.
Ganoderma – a therapeutic fungal biofactory.
Phytochemistry.
2006;
67
(18)
1985-2001
- 22
Sliva D.
Cellular and physiological effects of Ganoderma lucidum
(Reishi).
Mini Rev Med Chem.
2004;
4
(8)
873-879
- 23
Sliva D.
Ganoderma lucidum (Reishi) in cancer treatment.
Integr Cancer Ther.
2003;
2
(4)
358-364
- 24
Stanley G, Harvey K, Slivova V, Jiang J, Sliva D.
Ganoderma lucidum suppresses angiogenesis through the
inhibition of secretion of VEGF and TGF-beta1 from prostate cancer cells.
Biochem Biophys Res Commun.
2005;
330.
(1)
46-52
- 25
Thyagarajan A, Zhu J, Sliva D.
Combined effect of green tea and Ganoderma lucidum on
invasive behavior of breast cancer cells.
Int J Oncol.
2007;
30
(4)
963-969
- 26
Wachtel-Galor S, Tomlinson B, Benzie I F.
Ganoderma lucidum („Lingzhi”), a Chinese
medicinal mushroom: biomarker responses in a controlled human supplementation
study.
Br J Nutr.
2004;
91
(2)
263-269
- 27
Wang G, Zhao J, Liu J, Huang Y, Zhong J J, Tang W.
Enhancement of IL-2 and IFN-gamma expression and NK cells
activity involved in the anti-tumor effect of ganoderic acid Me in vivo.
Int Immunopharmacol.
2007;
7
(6)
864-870
- 28
Weng C J, Chau C F, Hsieh Y S, Yang S F, Yen G C.
Lucidenic acid inhibits PMA-induced invasion of human
hepatoma cells through inactivating MAPK/ERK signal transduction pathway and
reducing binding activities of NF-kappaB and AP-1.
Carcinogenesis.
2008;
29
(1)
147-156
- 29
Xie J T, Wang C Z, Wicks S, Yin J J, Kong J, Li J. et al .
Ganoderma lucidum extract inhibits proliferation of SW 480
human colorectal cancer cells.
Exp Oncol.
2006;
28
(1)
25-29
- 30 Yang Q Y, Wang M M. The effect of ganoderma lucidum extract against fatigue and
endurance in the absence of oxygen. In: Buchanan PK, Hseu RS, Moncalvo JM, editors.
5th Intl.
Mycol. Congr., Proc.Contributed.Symposium. 59A,B Taipe; 1995: 101-113
- 31 Yao P Y, Gao Z M, Fang S T, Ke L. Evaluation of the subsidiary effects of taking
PSP orally on
the chemotherapy of stomach cancer. In: Yang QY, Kwok CY, editors. 1993 PSP
Intl.
Symposium Shanghai; Fudan U. Press 1993: 269-270
- 32
Yue Q X, Cao Z W, Guan S H, Liu X H, Tao L, Wu W Y. et al .
Proteomic characterization of the cytotoxic mechanism of
ganoderic acid D and computer automated estimation of the possible drug-target
network.
Mol Cell Proteomics.
2007;
- 33
Yue G G, Fung K P, Tse G M, Leung P C, Lau C B.
Comparative studies of various ganoderma species and their
different parts with regard to their antitumor and immunomodulating activities
in vitro.
J Altern Complement Med.
2006;
12
(8)
777-789
- 34
Yue Q X, Xie F B, Guan S H, Ma c, Yang M, Jiang B H. et al .
Interaction of Ganoderma triterpenes with doxorubicin and
proteomic characterization of the possible molecular targets of Ganoderma
triterpenes.
Cancer Sci.
2008;
- 35
Zaidman B Z, Wasser S P.
Androgen receptor-dependent and -independent mechanisms
mediate Ganoderma lucidum activities in LNCaP prostate cancer cells.
Int J Oncol.
2007;
31
(4)
959-967
- 36
Zaidman B Z, Wasser S P.
Coprinus comatus and Ganoderma lucidum interfere with
androgen receptor function in LNCaP prostate cancer cells.
Mol Biol Rep.
2007;
- 37
Zhou X, Lin J, Yin Y, Zhao J, Sun X, Tang K.
Ganodermataceae: natural products and their related
pharmacological functions.
Am J Chin Med.
2007;
35
(4)
559-574
- 38
Zhu X L, Chen A F, Lin Z B.
Ganoderma lucidum polysaccharides enhance the function of
immunological effector cells in immunosuppressed mice.
J Ethnopharmacol.
2007;
111
(2)
219-226
Korrespondenzadresse
Prof. Dr. med. Arndt Büssing
Lehrstuhl für Medizintheorie
und
Komplementärmedizin
Universität
Witten/Herdecke
Gerhard-Kienle-Weg 4
58313 Herdecke
